We are pleased to announce that trial access to the CAS BioFinder Discovery Platform is now available for our Institute from October 15, 2026, through November 30, 2026.

CAS BioFinder brings together the data and solutions needed across drug discovery research teams, including discovery biology and medicinal chemistry. Our newest solution empowers your institution through comprehensive pharmaceutical data searchable by ligand, target, and disease, which is embedded into predictive technology and knowledge graphs. 

📅 Access Information

• Trial Period: October 15, 2026 – November 30, 2026

• Scope: Comprehensive access to published and predicted bioactivity data, ligand-protein interactions, biomarkers, and more.

• Login URL: biofinder.cas.org